Seehra Jasbir

CIK 0001732369

Chief Executive OfficerDirector

Filings

Latest Apr 6, 2026

Issuers covered

Showing

13 of 13

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+32.1%	+32.1%	+32.1%	+32.1%
90 days	1	100%	+33.7%	+33.7%	+33.7%	+33.7%
180 days	-	-	-	-	-	-
365 days	-	-	-	-	-	-

Companies where Seehra Jasbir has filed

Ticker	Issuer	Filings	Last filed
KROS	Keros Therapeutics, Inc.	12	Apr 6, 2026
ELOX	Eloxx Pharmaceuticals, Inc.	1	Jun 17, 2022

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Apr 6, 2026	KROSKeros Therapeutics, Inc.	MExercise	55,000	$0.30	$16,500
Feb 26, 2026	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Feb 20, 2026	KROSKeros Therapeutics, Inc.	SSale	7,015	$16.17	$113,433
Jan 9, 2026	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Sep 5, 2025	KROSKeros Therapeutics, Inc.	AGrant	90,500	$0.00	$0
Apr 7, 2025	KROSKeros Therapeutics, Inc.	MExercise	49,367	$0.30	$14,810
Feb 23, 2024	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Feb 15, 2024	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Apr 11, 2023	KROSKeros Therapeutics, Inc.	MExercise	4,000	$0.48	$1,920
Feb 17, 2023	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Jun 17, 2022	ELOXEloxx Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 10, 2022	KROSKeros Therapeutics, Inc.	MExercise	5,000	$0.30	$1,500
Jan 25, 2022	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.